Ancora Heart
Pre-clinicalAncora Heart, a medical device company, has developed AccuCinch®, the first percutaneous ventricular restoration system designed to treat heart failure.
Founded
2009
Focus
CardiovascularMedical Devices
About
Ancora Heart, a medical device company, has developed AccuCinch®, the first percutaneous ventricular restoration system designed to treat heart failure.
Funding History
3Total raised: $145M
Series C$80MPerceptive AdvisorsAug 15, 2022
Series B$40MDeerfield ManagementNov 15, 2020
Series A$25MSanderling VenturesApr 15, 2018
Company Info
TypePrivate
Founded2009
LocationSanta Clara, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile